Could greek yogurt help Post-Menopausal women build muscle and control blood sugar?

NCT ID NCT07705724

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study investigates whether eating two servings of Greek yogurt daily—either whole milk or skimmed—can improve muscle protein synthesis, blood sugar control, and thinking skills in post-menopausal women who are overweight or have obesity. Participants will follow a standardized diet with one type of yogurt for a set period. The goal is to see if this common food can offer health benefits during and after menopause.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Greek yogurt (skimmed or whole milk)
What this could lead to
If it works, this could point toward a simple dietary strategy to support muscle health and blood sugar control in post-menopausal women.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply broadly. The effect of yogurt on these outcomes may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Apr 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 50 to 65 years 2. Body mass index ≥25 to \<40 kg/m2 or body fat ≥36% 3. Able to provide informed consent 4. Absence of menstruation for ≥12 months without the use of hormonal contraceptives, or one of the following: * Another medical cause of menopause e.g., history of bilateral oophorectomy * Clinician-confirmed menopausal status for those with hysterectomy and retained/unknown ovaries * Partial/total hysterectomy ≥12 months ago and current age ≥55 years Exclusion Criteria: 1. Allergy or intolerance to dairy products (other allergies or intolerances may be excluded if they are not compatible with the study meals and how they are prepared) 2. Conditions, medications, or recent changes in medications that cause participants to be metabolically unstable (e.g., renal, cardiovascular, thyroid, polycystic ovary syndrome, type-1 and type-2 diabetes) 3. Gastric bypass/bariatric surgery in the previous 5 years 4. Pregnancy or nursing in the prior 12 months 5. Weight loss or gain \>5 kg in the last two months 6. Unable or unwilling to suspend use of blood thinning medications and non-steroidal anti-inflammatory drugs for the duration of the study 7. Unwilling to abstain from vigorous exercise for the study period 8. Does not or will not eat all foods on the standardized diet (e.g., allergies, intolerances, or taste preferences) 9. Participants may be excluded at the Principal Investigator's discretion if their health or body composition is not compatible with the required study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopause are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, 72205, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.